2-Cyclododecylpropan-1-ol
Common Name: |
2-Cyclododecylpropan-1-ol |
IUPAC Name: |
2-cyclododecylpropan-1-ol |
Molecular Formula: |
C15H30O |
SMILES: |
CC(CO)C1CCCCCCCCCCC1 |
Inchi: |
1S/C15H30O/c1-14(13-16)15-11-9-7-5-3-2-4-6-8-10-12-15/h14-16H,2-13H2,1H3 |
Inchi Key: |
WKHTUDYDJUHYMK-UHFFFAOYSA-N |
Cas No: |
118562-73-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
226.40 |
Mass (g/mol) |
226.23 |
Molar Refractivity |
73.27 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
34.00 |
Boiling Point (°C@760.00mm Hg) |
300.00 to 308.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
4.536 |
iLOGP |
3.22 |
XLOGP3 |
6.32 |
WLOGP |
4.54 |
MLOGP |
3.81 |
ESOL Log S |
-5.09 |
ESOL Solubility (mg/ml) |
0.002 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-6.53 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-3.26 |
Silicos-IT Solubility (mg/ml) |
0.12 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.908 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.391 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |